We are pleased to announce that the virtual 15th Annual European Life Sciences CEO Forum (ELSF) will take place on the 1st-2nd of March 2022 and be part of the digital Sachs Spring Life Sciences Week, that will also incorporate the 3rd Annual European HealthTech CEO Forum.
Back for its 15th Annual Edition, this global bio-pharma industry event will address the main challenges for 2022, including investment, partnering and alliance management. Key players contribute their insights in panels which cover the macro picture as well as innovation in different therapeutic sectors.
The main programme for the 15th Annual ELSF is spread throughout 2 days (1st-2nd of March) and will include BioCapital & Investment Day and Bio-Pharma Partnering & Therapeutics Day. The two days will feature more than 12 hours of high-level speeches and panel discussions. In addition, there will be 50+ presentations by globally established public, private, emerging and seed companies who offer innovation solutions and are seeking investment and partnering opportunities. We anticipate 400+ delegates will register for the forum from all Life Sciences sectors, with the target audience being corporate and financial investors/partners, bankers and advisors.
The virtual meetings will take place from the 28th February to 4th of March. Moreover, the system will be open for 12 hours a day and we expect 1500+ meetings completed over 5 days. The conference will be held in the Central European Time Zone. The digital event will consist of:
BioCapital & Investment Day (Tuesday, 1st of March)
Bio-Pharma Partnering & Therapeutics Day (Wednesday, 2nd of March)